A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie Miller, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Ajjai Alva, Mehmet Asım Bilen, Tyler F. Stewart, Víctor Sacristán Santos, Neeraj Agarwal, Jayanshu Jain, Yousef Zakharia, Rafael Morales‐Barrera, Michael Devitt, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Benjamin A. Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Alejo Rodríguez‐Vida, Alexandra Drakaki, Sandy Liu, Vivek Kumar, Mark P. Lythgoe, David J. Pinato, Jure Murgić, Ana Fröbe, Monika Joshi, Pedro Isaacsson Velho, Noah M. Hahn, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Pedro C. Barata, Matthew D. Galsky, Guru Sonpavde, Evan Y. Yu, Veena Shankaran, Gary H. Lyman, Petros Grivas